726419

2-(氯甲基)萘

≥97.0%

• 同義詞: β-Naphthylmethyl chloride, 2-Menaphthyl chloride, 2-Naphthylmethyl chloride
• 經驗公式（希爾表示法）: C₁₁H₉Cl
• CAS號碼: 2506-41-4
• 分子量：: 176.64
• Beilstein: 742185
• EC號碼: 219-713-5
• MDL號碼: MFCD00046488
• 分類程式碼代碼: 12352100
• PubChem物質ID: 329764234
• NACRES: NA.22

屬性

• 品質等級: 100
• 化驗: ≥97.0% (GC); ≥97.0%; 97.0-103.0% (T)
• 形狀: crystals
• SMILES 字串: ClCc1ccc2ccccc2c1
• InChI: 1S/C11H9Cl/c12-8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7H,8H2
• InChI 密鑰: MPCHQYWZAVTABQ-UHFFFAOYSA-N

描述

應用

• Improving insulin sensitivity: Research highlights dihydroberberine′s capacity to enhance insulin sensitivity through AMPK activation, offering a promising therapeutic strategy for managing insulin resistance and type 2 diabetes (Lewis and Falk, 2022).



• Anti-inflammatory effects: A study conducted on the anti-inflammatory properties of dihydroberberine found significant reductions in inflammatory markers, suggesting its potential as an anti-inflammatory agent in metabolic syndrome (Dian et al., 2022).



• Enhancing bioavailability: Investigations into the oral bioavailability of dihydroberberine demonstrate improvements over its precursor berberine, highlighting its superior pharmacokinetic profile which could lead to more effective clinical applications (Murakami, Bodor, and Bodor, 2023).



• Glucose uptake mechanisms: Studies on dihydroberberine have shown its effectiveness in facilitating glucose uptake, an essential function for metabolic health, through its interaction with cellular transport mechanisms (Moon et al., 2021).

安全資訊

• 象形圖: GHS05
• 訊號詞: Danger
• 危險聲明: H314
• 防範說明: P280 - P305 + P351 + P338 - P310
• 危險分類: Skin Corr. 1B
• 儲存類別代碼: 8A - Combustible corrosive hazardous materials
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable